Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOSENSE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.3% 2.3%   Bankruptcy risk   3.3% 3.6% 6.4% 15.6% 7.2% 5.2% 11.7% 11.7%   Credit score (0-100)   56 54 37 11 33 42 20 20   Credit rating   BBB BBB BBB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   107 18.7 68.3 -1.7 194 237 0.0 0.0   EBITDA   46.2 -33.5 23.6 -47.0 160 42.8 0.0 0.0   EBIT   33.0 -46.7 10.4 -60.2 160 42.8 0.0 0.0   Pre-tax profit (PTP)   -42.6 47.9 46.1 -63.2 157.3 42.2 0.0 0.0   Net earnings   -36.7 37.3 35.9 -66.5 139.8 32.8 0.0 0.0   Pre-tax profit without non-rec. items   -42.6 47.9 46.1 -63.2 157 42.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   39.6 26.4 13.2 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,000 929 855 675 701 733 608 608   Interest-bearing liabilities   0.0 78.8 0.0 0.1 0.1 0.1 0.0 0.0   Balance sheet total (assets)   1,067 1,050 958 704 791 1,058 608 608   Net Debt   -578 -455 -535 -292 -463 -519 -608 -608     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   107 18.7 68.3 -1.7 194 237 0.0 0.0   Gross profit growth   -22.7% -82.6% 265.4% 0.0% 0.0% 22.1% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,067 1,050 958 704 791 1,058 608 608   Balance sheet change%   -2.2% -1.6% -8.8% -26.5% 12.3% 33.8% -42.5% 0.0%   Added value   46.2 -33.5 23.6 -47.0 173.0 42.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -26 -26 -26 -26 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   30.8% -250.0% 15.2% 3,644.3% 82.5% 18.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.3% 4.5% 5.3% -7.2% 21.4% 4.7% 0.0% 0.0%   ROI %   4.5% 4.8% 5.8% -7.9% 23.2% 6.0% 0.0% 0.0%   ROE %   -3.6% 3.9% 4.0% -8.7% 20.3% 4.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   93.7% 88.5% 89.2% 95.9% 88.6% 69.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,250.3% 1,356.3% -2,270.7% 621.8% -289.8% -1,213.2% 0.0% 0.0%   Gearing %   0.0% 8.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.3% 19.2% 10,062.3% 4,095.1% 1,416.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   9.3 5.1 5.2 10.3 6.1 2.5 0.0 0.0   Current Ratio   15.3 8.5 9.2 24.4 8.8 3.3 0.0 0.0   Cash and cash equivalent   577.6 533.8 535.0 292.1 463.2 519.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   548.9 407.0 841.4 675.2 700.7 733.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   46 -34 24 -47 173 43 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   46 -34 24 -47 160 43 0 0   EBIT / employee   33 -47 10 -60 160 43 0 0   Net earnings / employee   -37 37 36 -66 140 33 0 0